PT Kimia Farma (Persero) Tbk

IDX:KAEF.JK

695 (IDR) • At close October 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) IDR.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 9,965,033.0499,606,145.35912,857,626.59310,006,173.0239,400,535.4767,454,114.7416,127,479.3695,811,502.6564,860,371.4844,521,024.384,348,073.9883,734,241.1013,481,166.4413,183,829.3042,854,057.692,704,728.41
Cost of Revenue 7,155,170.2036,013,310.3258,461,341.4946,349,041.8325,897,247.794,673,936.4463,925,599.7243,947,606.9333,323,619.2973,135,542.323,055,921.9472,559,074.132,443,150.4872,279,309.9942,065,807.5551,982,480.481
Gross Profit 2,809,862.8463,592,835.0344,396,285.0993,657,131.1913,503,287.6862,780,178.2952,201,879.6451,863,895.7241,536,752.1861,385,482.061,292,152.0411,175,166.9711,038,015.954904,519.31788,250.136722,247.928
Gross Profit Ratio 0.2820.3740.3420.3650.3730.3730.3590.3210.3160.3060.2970.3150.2980.2840.2760.267
Reseach & Development Expenses 100,972.68346,365.01941,348.215,527.14215,323.73218,069.43537,429.12724,454.14419,134.43815,270.1717,253.99314,785.7190000
General & Administrative Expenses 573,593.518321,906.127378,335.92416,360.471485,087.615302,073.291246,111.938195,805.22172,564.423180,310.175143,986.972123,789.471328,039.025321,239.714282,473.584258,718.192
Selling & Marketing Expenses 890,451.578669,494.907651,012.953752,088.461939,966.198526,953.533439,862310,233.783237,605.975125,737.931236,674.326212,813.176487,973.08437,081.154393,843.105356,493.168
SG&A 4,027,630.042991,401.0341,029,348.8731,168,448.9321,425,053.813829,026.824685,973.938506,039.003410,170.399875,033.396380,661.298336,602.647816,012.105758,320.868676,316.69615,211.36
Other Expenses -243,143.4432,202,992.8552,401,009.8011,980,053.1811,771,479.652118,836.93776,478.55237,259.03934,304.8247,592.02322,738.09417,611.053043,072.52400
Operating Expenses 4,371,746.1683,240,758.9083,471,706.8743,164,029.2553,211,857.1972,183,974.311,777,805.5121,459,859.9051,219,606.5761,099,831.4131,042,618.887912,599.414816,012.105758,320.868676,316.69615,211.36
Operating Income -1,561,883.322558,071.583985,639.32653,024.422501,655.742765,017.358535,661.371442,824.104374,277.147342,480.745293,765.074285,156.855222,003.849146,198.442111,933.446107,036.569
Operating Income Ratio -0.1570.0580.0770.0650.0530.1030.0870.0760.0770.0760.0680.0760.0640.0460.0390.04
Total Other Income Expenses Net -605,731.252-508,449.528-592,755.911-579,665.324-463,340.254-18,477.65825,635.63-21,009.89420,989.4529,960.41234,592.27815,716.89510,003.21132,412.796-12,203.625-10,930.712
Income Before Tax -2,167,614.57449,622.055392,883.40973,359.09838,315.488577,726.328449,709.762383,025.925338,135.061315,611.06284,125.432278,284.452232,007.06178,611.23899,729.82196,105.856
Income Before Tax Ratio -0.2180.0050.0310.0070.0040.0780.0730.0660.070.070.0650.0750.0670.0560.0350.036
Income Tax Expense -365,570.497143,948.941102,994.6252,933.34222,425.049175,933.519118,001.845111,427.97785,162.55579,079.98968,483.10272,520.45560,243.88439,894.77937,222.94440,712.081
Net Income -1,485,563.806-94,326.886302,273.63417,638.83415,890.439415,895.778326,786.249267,414.093248,849.016234,625.679214,549.154205,133.317171,765.487138,716.04462,506.87755,393.775
Net Income Ratio -0.149-0.010.0240.0020.0020.0560.0530.0460.0510.0520.0490.0550.0490.0440.0220.02
EPS -267.48-16.9854.423.182.8674.8858.8448.1547.0746.0838.6336.9330.9324.9811.259.97
EPS Diluted -267.48-16.9854.423.182.8674.8858.8448.1547.0746.0838.6336.9330.9324.9811.259.97
EBITDA -868,445.342794,708.021,229,361.171817,047.543604,038.671842,555.224578,532.201491,121.94408,334.526342,480.745293,887.626300,879.09222,003.849146,198.44299,672.38398,307.103
EBITDA Ratio -0.0870.0830.0960.0820.0640.1130.0940.0850.0840.0760.0680.0810.0640.0460.0350.036